Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,164,918
+$3,460,896 QoQ
Shares Held
20,147
-10.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#819
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $116,130,341 across 15 Drug Manufacturers - General names. LLY ranks #1 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
20,147 | $24,164,918 | |
| 2 | JNJ |
Johnson & Johnson
|
77,048 | $19,567,880 | |
| 3 | ABBV |
AbbVie Inc.
|
56,848 | $14,305,230 | |
| 4 | MRK |
Merck & Co., Inc.
|
88,627 | $11,388,569 | |
| 5 | AZN |
Astrazeneca PLC
|
50,534 | $9,582,257 | |
| 6 | NVS |
Novartis AG
|
61,000 | $9,559,920 | |
| 7 | AMGN |
Amgen Inc
|
16,658 | $6,032,194 | |
| 8 | NVO |
Novo Nordisk A S
|
115,512 | $5,537,645 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,164,918 | 20,147 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $20,704,022 | 22,510 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $23,387,188 | 21,762 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,248,262 | 18,674 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $14,274,753 | 18,312 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $16,964,191 | 20,540 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,995,604 | 10,357 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,752,427 | 11,008 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $10,124,864 | 11,183 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $8,456,425 | 10,870 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,193,525 | 10,625 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $5,647,921 | 10,515 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,510,649 | 9,618 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,183,846 | 9,271 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,209,148 | 8,772 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,746,534 | 8,494 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,600,973 | 8,022 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,178,702 | 7,608 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,969,724 | 7,131 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,617,812 | 7,002 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,601,131 | 6,976 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,264,397 | 6,768 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,043,431 | 6,180 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $834,980 | 5,641 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $962,751 | 5,864 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,535,325 | 11,068 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||